MEIS1 was downregulated in most tumors, and high MEIS1 expression predicted better OS in patients with HNSCC, adrenocortical carcinoma, and clear cell renal carcinoma [84]. This evidence concerns the gene MEIS1 and clear cell renal carcinoma.